Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Single Intravenous Dose, Exploratory Dose-finding, Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP) in RhD Positive, Non-splenectomized Adult Subjects.

NCT00718692 is registered in ClinicalTrials.gov with Symphogen A/S as lead sponsor.

NCT NCT00718692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00718692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Single Intravenous Dose, Exploratory Dose-finding, Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP) in RhD Positive, Non-splenectomized Adult Subjects.
Lead sponsor
Symphogen A/S
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2008
Completion date
October 31, 2011
Enrollment
61 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenic purpura